Impact of five ‐tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high‐dose‐rate brachytherapy

ConclusionsStage T3a patients with grade groups 4/5 and stage T3b with grade group 4 had fairly low PCSM risk. Approximately one of four patients among stage T3b patients with grade group 5 showed PCSM after combined HDR‐BT and EBRT with long‐term ADT. Stage T3b patients with grade group 5 may have a greater risk for PCSM.

Source: The Prostate - September 14, 2017 Category: Urology & Nephrology Authors: Hideyasu Tsumura, Hiromichi Ishiyama, Ken ‐ichi Tabata, Hiroki Katsumata, Momoko Kobayashi, Masaomi Ikeda, Shinji Kurosaka, Tetsuo Fujita, Masashi Kitano, Takefumi Satoh, Nobuyuki Yanagisawa, Kazushige Hayakawa, Masatsugu Iwamura Tags: ORIGINAL ARTICLE Source Type: research